AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35070197 — intervention group
Group type: EXPERIMENTAL
Intervention: NASM exercise program
Number of subjects: 33
Study 35070197 — intervention group
Group type: EXPERIMENTAL
Intervention: PRI exercise program
Number of subjects: 33
Study 35070197 — intervention group
Group type: EXPERIMENTAL
Intervention: NASM-PRI integration exercise program
Number of subjects: 33
Study 32108364 — intervention group
Group type: EXPERIMENTAL
Intervention: Deterministic statements
Number of subjects: 0
Study 32108364 — intervention group
Group type: COMPARATOR
Intervention: Control statements
Number of subjects: 0
Study 36281908 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided cannulation
Number of subjects: 50
Study 36281908 — intervention group
Group type: COMPARATOR
Intervention: Conventional cannulation
Number of subjects: 50
Study 34103643 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI < 25 kg/m2
Number of subjects: 1319
Study 34103643 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥ 5 servings of fruits or vegetables/day
Number of subjects: 1319
Study 34103643 — intervention group
Group type: EXPERIMENTAL
Intervention: ≤ 2 alcoholic drinks/day for men or 1 drink/day for women
Number of subjects: 1319
Study 34103643 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥ 30 min of moderate or vigorous physical activity/day
Number of subjects: 1319
Study 33222306 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 36081312 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue elevation training for 6 weeks
Number of subjects: 27
Study 36081312 — intervention group
Group type: COMPARATOR
Intervention: Sham training protocol (control) for 6 weeks
Number of subjects: 27
Study 33358350 — intervention group
Group type: EXPERIMENTAL
Intervention: GTN sublingual powder
Number of subjects: 73
Study 33358350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 32817724 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-commercial funders with a data-sharing policy
Number of subjects: 178
Study 32817724 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial funders with a data-sharing policy
Number of subjects: 178
Study 32817724 — intervention group
Group type: COMPARATOR
Intervention: RCTs funded by non-commercial funders
Number of subjects: 178
Study 32817724 — intervention group
Group type: COMPARATOR
Intervention: RCTs funded by commercial funders
Number of subjects: 178
Study 35847464 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-directed medication reconciliation
Number of subjects: 123
Study 35847464 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pharmacist-directed medication reconciliation)
Number of subjects: 123
Study 34874631 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery and platinum-based chemotherapy
Number of subjects: 407
Study 34874631 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 407
Study 34874631 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (complete resection)
Number of subjects: 407
Study 34874631 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life measures
Number of subjects: 407
Study 34874631 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative mortality
Number of subjects: 407
Study 34387227 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Intelligence (AI) convolutional neural networks (CNN)
Number of subjects: 143
Study 34387227 — intervention group
Group type: COMPARATOR
Intervention: Control group assessment
Number of subjects: 143
Study 34387227 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert radiologist aided by AI
Number of subjects: 143
Study 34883480 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised multidisciplinary education programme
Number of subjects: 142
Study 34883480 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 142
Study 34277507 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 60
Study 34277507 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 60
Study 34277507 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training (CT)
Number of subjects: 60
Study 34277507 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 34298113 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed oblong tablets
Number of subjects: 12
Study 34298113 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed round tablets
Number of subjects: 12
Study 34298113 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed football
Number of subjects: 12
Study 34298113 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed sphere
Number of subjects: 12
Study 34298113 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed pyramid
Number of subjects: 12
Study 34298113 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed cuboctahedron
Number of subjects: 12
Study 34298113 — intervention group
Group type: COMPARATOR
Intervention: Compressed placebo reference objects
Number of subjects: 12
Study 32444968 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pass-filtered sentence intonation (SI-LPF) test
Number of subjects: 17
Study 32444968 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentence test with adaptive randomized roving level (STARR)
Number of subjects: 17
Study 32444968 — intervention group
Group type: COMPARATOR
Intervention: Sentence recognition tests presented in quiet (SRQ)
Number of subjects: 17
Study 32444968 — intervention group
Group type: COMPARATOR
Intervention: Fixed signal-to-noise ratios (SNRs at +10 dB)
Number of subjects: 17
Study 32444968 — intervention group
Group type: COMPARATOR
Intervention: Fixed signal-to-noise ratios (SNRs at +5 dB)
Number of subjects: 17
Study 33279463 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Fat, High-Protein Meat (HFPM) diet
Number of subjects: 8
Study 33279463 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Carbohydrate Vegan (HCV) diet
Number of subjects: 8
Study 33074848 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NIPPV)
Number of subjects: 19
Study 33074848 — intervention group
Group type: COMPARATOR
Intervention: Sham ventilation
Number of subjects: 19
Study 33074848 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPPV
Number of subjects: 19
Study 34746997 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (3mg) plus Tamsulosin (0.4mg)
Number of subjects: 108
Study 34746997 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus Tamsulosin (0.4mg)
Number of subjects: 108
Study 33793743 — intervention group
Group type: EXPERIMENTAL
Intervention: OABP+ (Oral Antibiotic Prophylaxis with Mechanical Bowel Preparation)
Number of subjects: 600
Study 33793743 — intervention group
Group type: COMPARATOR
Intervention: OABP- (No Oral Antibiotic Prophylaxis with Mechanical Bowel Preparation)
Number of subjects: 600
Study 33793743 — intervention group
Group type: EXPERIMENTAL
Intervention: OABP+
Number of subjects: 600
Study 33793743 — intervention group
Group type: COMPARATOR
Intervention: OABP-
Number of subjects: 600
Study 32694544 — intervention group
Group type: COMPARATOR
Intervention: FSBM0 (27% SBM + 0% FSBM)
Number of subjects: 39
Study 32694544 — intervention group
Group type: EXPERIMENTAL
Intervention: FSBM9 (18% SBM + 9% FSBM)
Number of subjects: 39
Study 32694544 — intervention group
Group type: EXPERIMENTAL
Intervention: FSBM13 (13.5% SBM + 13.5% FSBM)
Number of subjects: 39
Study 33242717 — intervention group
Group type: EXPERIMENTAL
Intervention: Bikram yoga
Number of subjects: 53
Study 33242717 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 53
Study 33242717 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 53
Study 32338532 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischaemic compression (IC)
Number of subjects: 54
Study 32338532 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 54
Study 32338532 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study 32437711 — intervention group
Group type: EXPERIMENTAL
Intervention: RFA + S-1
Number of subjects: 75
Study 32437711 — intervention group
Group type: COMPARATOR
Intervention: RFA
Number of subjects: 75
Study 36416000 — intervention group
Group type: EXPERIMENTAL
Intervention: IWL (internet weight-loss intervention only)
Number of subjects: 550
Study 36416000 — intervention group
Group type: EXPERIMENTAL
Intervention: IWL + PCP (internet weight-loss intervention plus semiautomated feedback from the provider)
Number of subjects: 550
Study 36416000 — intervention group
Group type: COMPARATOR
Intervention: EUC (usual care)
Number of subjects: 550
Study 33218552 — intervention group
Group type: EXPERIMENTAL
Intervention: Squats performed with 60% of 1-RM
Number of subjects: 14
Study 33218552 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional exercises (sit-to-stand, lunges, and step-ups)
Number of subjects: 14
Study 33218552 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling and running
Number of subjects: 14
Study 34949502 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TA) drops
Number of subjects: 90
Study 34949502 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone (OP)
Number of subjects: 90
Study 34949502 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study 32037862 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure garment application (long glove) for 6 hours/day in addition to 2 hours/week conventional occupational therapy
Number of subjects: 46
Study 32037862 — intervention group
Group type: COMPARATOR
Intervention: Conventional occupational therapy for 2 hours/week
Number of subjects: 46
Study 36194950 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel (25 mg/m2, 6 cycles, three-weekly)
Number of subjects: 158
Study 36194950 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel (80 mg/m2, weekly)
Number of subjects: 158
Study 36194950 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Number of subjects: 158
Study 36194950 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 158
Study 35551978 — intervention group
Group type: EXPERIMENTAL
Intervention: Qirui Weishu capsule
Number of subjects: 477
Study 35551978 — intervention group
Group type: COMPARATOR
Intervention: Sanjiu Weitai capsule
Number of subjects: 477
Study 34380364 — intervention group
Group type: EXPERIMENTAL
Intervention: Titrated CCRT
Number of subjects: 201
Study 34380364 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-titrated CCRT
Number of subjects: 201
Study 34380299 — intervention group
Group type: EXPERIMENTAL
Intervention: Local magneto-therapy
Number of subjects: 114
Study 34380299 — intervention group
Group type: EXPERIMENTAL
Intervention: General magneto-therapy
Number of subjects: 114
Study 34380299 — intervention group
Group type: COMPARATOR
Intervention: Control group (therapeutic exercises only)
Number of subjects: 114
Study 32160755 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTG 5366 trial participation
Number of subjects: 31
Study 32160755 — intervention group
Group type: EXPERIMENTAL
Intervention: Reimbursements to defray costs of study participation
Number of subjects: 31
Study 32160755 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding of risks and benefits
Number of subjects: 31
Study 32160755 — intervention group
Group type: EXPERIMENTAL
Intervention: Stigma as a motivator
Number of subjects: 31
Study 34480330 — intervention group
Group type: EXPERIMENTAL
Intervention: Active deep brain stimulation (DN DBS)
Number of subjects: 5
Study 34480330 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 5
Study 33320296 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition 1: Walking without any irritation
Number of subjects: 7
Study 33320296 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition 2: Imitated sacculus irritation using a standardized cVEMP signal
Number of subjects: 7
Study 33320296 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition 3: Electric neck muscle-irritation (TENS)
Number of subjects: 7
Study 33393688 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt Mental Health Care (PMHC)
Number of subjects: 839
Study 33393688 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 839
Study 32102662 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich diet (PR-diet)
Number of subjects: 50
Study 32102662 — intervention group
Group type: COMPARATOR
Intervention: Control diet (C-diet)
Number of subjects: 50
Study 35652491 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive IV fluid administration (24 hours)
Number of subjects: 123
Study 35652491 — intervention group
Group type: COMPARATOR
Intervention: Standard care (at the discretion of the treating team)
Number of subjects: 123
Study 35652491 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive IV fluid administration
Number of subjects: 123
Study 35652491 — intervention group
Group type: COMPARATOR
Intervention: Restrictive IV fluid administration and Standard care
Number of subjects: 123
Study 34411264 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir (or trimethoprim‐sulfamethoxazole for intolerant patients) for 7 days after surgery
Number of subjects: 113
Study 34411264 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 7 days after surgery
Number of subjects: 113
Study 34411264 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir (or trimethoprim‐sulfamethoxazole for intolerant patients)
Number of subjects: 113
Study 34411264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study 32593627 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable circumcision suture device
Number of subjects: 284
Study 32593627 — intervention group
Group type: COMPARATOR
Intervention: Conventional dorsal slit circumcision
Number of subjects: 284
Study 36066862 — intervention group
Group type: COMPARATOR
Intervention: Medication management (MM)
Number of subjects: 947
Study 36066862 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication management plus combined behavioral intervention (MMCBI)
Number of subjects: 947
Study 36066862 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 947
Study 34086781 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-of-pocket (OOP) payments for healthcare in HDP areas
Number of subjects: 3791
Study 34086781 — intervention group
Group type: COMPARATOR
Intervention: Out-of-pocket (OOP) payments for healthcare in LDP areas
Number of subjects: 3791
Study 34086781 — intervention group
Group type: EXPERIMENTAL
Intervention: Catastrophic healthcare expenditure
Number of subjects: 3791
Study 34086781 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-communicable diseases (NCDs)
Number of subjects: 3791
Study 34086781 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall impoverishment due to OOP payments
Number of subjects: 3791
Study 35494290 — intervention group
Group type: EXPERIMENTAL
Intervention: Theracurmin at 180 mg per day
Number of subjects: 50
Study 35494290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 32936242 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic SAE (pSAE)
Number of subjects: 133
Study 32936242 — intervention group
Group type: COMPARATOR
Intervention: Surveillance (SURV)
Number of subjects: 133
Study 33433317 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib citrate test formulation (T)
Number of subjects: 72
Study 33433317 — intervention group
Group type: COMPARATOR
Intervention: tofacitinib citrate reference formulation (R)
Number of subjects: 72
Study 35986905 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intervention for less chronic heart failure (NIL-CHF)
Number of subjects: 454
Study 35986905 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal echocardiogram
Number of subjects: 454
Study 35986905 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular diastolic dysfunction/left ventricular systolic dysfunction (LVDD/LVSD)
Number of subjects: 454
Study 35986905 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural heart disease
Number of subjects: 454
Study 35986905 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality
Number of subjects: 454
Study 34465695 — intervention group
Group type: EXPERIMENTAL
Intervention: Linaclotide 290 μg daily for 12 weeks
Number of subjects: 614
Study 34465695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 614
Study 32886256 — intervention group
Group type: EXPERIMENTAL
Intervention: TEP
Number of subjects: 100
Study 32886256 — intervention group
Group type: COMPARATOR
Intervention: TAPP
Number of subjects: 100
Study 32911214 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 20
Study 32911214 — intervention group
Group type: COMPARATOR
Intervention: Control (laboratory tests and free ART medication)
Number of subjects: 20
Study 36120840 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrahigh-translucent monolithic zirconia (group Z)
Number of subjects: 30
Study 36120840 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-matrix ceramic (group C)
Number of subjects: 30
Study 36120840 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyetherketoneketone veneered with light-cured composite resin (group P)
Number of subjects: 30
Study 33089368 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (transcutaneous electrical nerve stimulation, hot pack, ultrasound treatments, Codman's and range of motion exercises)
Number of subjects: 90
Study 33089368 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneotherapy added to physical therapy
Number of subjects: 90
Study 35551237 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompression and drainage seton (DADS)
Number of subjects: 120
Study 35551237 — intervention group
Group type: COMPARATOR
Intervention: Cutting seton (CS)
Number of subjects: 120
Study 32484432 — intervention group
Group type: EXPERIMENTAL
Intervention: Carer administration of as-needed subcutaneous medication (intervention group)
Number of subjects: 40
Study 32484432 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 40
Study 32484432 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recruitment
Number of subjects: 40
Study 32484432 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall retention
Number of subjects: 40
Study 36175107 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberate practice training using role-play and Skillsetter, an online skill-building system with therapy videos, for 15 hours of classroom participation and homework.
Number of subjects: 200
Study 36175107 — intervention group
Group type: COMPARATOR
Intervention: Theoretical teaching for 15 hours of classroom participation and homework.
Number of subjects: 200
Study 36175107 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberate practice training
Number of subjects: 200
Study 33462097 — intervention group
Group type: EXPERIMENTAL
Intervention: DAFNEplus intervention
Number of subjects: 662
Study 33462097 — intervention group
Group type: COMPARATOR
Intervention: Standard DAFNE
Number of subjects: 662
Study 32409561 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine plus standard of care
Number of subjects: 150
Study 32409561 — intervention group
Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 150
Study 32409561 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine recipients
Number of subjects: 150
Study 32409561 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine non-recipients
Number of subjects: 150
Study 35034532 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimised regimen (7 × 2 L 2.27% glucose + 5 × 2 L 0.1% glucose over 8 h)
Number of subjects: 21
Study 35034532 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen (6 × 2 L 1.36% glucose over 9 h)
Number of subjects: 21
Study 33354953 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological nursing
Number of subjects: 160
Study 34511283 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOICES Decision Aid (DA)
Number of subjects: 101
Study 34511283 — intervention group
Group type: COMPARATOR
Intervention: National Cancer Institute (NCI) Cancer Clinical Trials (CCT) website
Number of subjects: 101
Study 32542644 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV-vaccine
Number of subjects: 6203
Study 32542644 — intervention group
Group type: COMPARATOR
Intervention: Prevaccination data
Number of subjects: 6203
Study 36104302 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibegron 75 mg as an intact tablet
Number of subjects: 30
Study 36104302 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibegron 75 mg crushed and mixed with applesauce
Number of subjects: 30
Study 36104302 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibegron 75 mg (both intact and crushed)
Number of subjects: 30
Study 36104302 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibegron and applesauce mixture
Number of subjects: 30
Study 36104302 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibegron crushed and mixed with applesauce
Number of subjects: 30
Study 33963943 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% EGCG solution + RelyX U200
Number of subjects: 144
Study 33963943 — intervention group
Group type: COMPARATOR
Intervention: 2% chlorhexidine (CHX) solution
Number of subjects: 144
Study 33963943 — intervention group
Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 144
Study 33963943 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional resin cement
Number of subjects: 144
Study 33963943 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal cycling (5 °C/55 °C, 12,000 cycles)
Number of subjects: 144
Study 33327746 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower HDL cholesterol (1 mmol/L or 39 mg/dL)
Number of subjects: 107952
Study 33327746 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined lower HDL cholesterol (1 mmol/L or 39 mg/dL)
Number of subjects: 107952
Study 33851547 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Dot (GD) training after high school
Number of subjects: 1831
Study 33851547 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no additional GD training)
Number of subjects: 1831
Study 33851547 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional GD training after RCT
Number of subjects: 1831